Previous close | 385.05 |
Open | 387.64 |
Bid | 381.82 x 100 |
Ask | 382.53 x 100 |
Day's range | 381.24 - 389.27 |
52-week range | 185.43 - 419.42 |
Volume | |
Avg. volume | 253,480 |
Market cap | 11.849B |
Beta (5Y monthly) | 1.40 |
PE ratio (TTM) | 43.12 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CINCINNATI, March 28, 2024--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.
CINCINNATI, February 12, 2024--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the fourth quarter and full year ended December 31, 2023.
CINCINNATI, January 03, 2024--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024. The Company will host a conference call the following morning, Tuesday, February 13, 2024, at 9:00 a.m. ET to discuss these results.